Zonisamide Capsule
Product Images NDC 68001-244

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 68001-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Formula Of Zonisamide (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 01)

Chemical Formula Of Zonisamide (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 01)
FDA Label Image

Figure 1: Proportion Of Patients Achieving Differing Levels Of Seizure Reduction In Zonisamide And Placebo Groups In Studies 2 And 3 (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 02)

Figure 1: Proportion Of Patients Achieving Differing Levels Of Seizure Reduction In Zonisamide And Placebo Groups In Studies 2 And 3 (345efcc4 6a36 4ddf 8b6c 9c6c844dab0a 02)
FDA Label Image

Zonisamide Capsules 100mg 100 Capsules Rev 03-17 (Zonisamide Capsules 100mg 100 Capsules Rev 0714)

Zonisamide Capsules 100mg 100 Capsules Rev 03-17 (Zonisamide Capsules 100mg 100 Capsules Rev 0714)
This is a drug information label for a pharmaceutical product manufactured by Glenmark Pharmaceuticals Ltd. The medication, containing 100mg of Zonisamide, is produced for BluePoint Laboratories. The label includes instructions for storage, dispensing to patients by a pharmacist, and a contact number for questions. There is also a note for patients to refer to an accompanying medication guide, available online at the Glenmark Pharmaceuticals website.*
FDA Label Image

Zonisamide Capsules 25mg 100 Capsules Rev 03-17 (Zonisamide Capsules 25mg 100 Capsules Rev 0714)

Zonisamide Capsules 25mg 100 Capsules Rev 03-17 (Zonisamide Capsules 25mg 100 Capsules Rev 0714)
This is a medication label for Zonisamide capsules, USP, with a strength of 25 mg manufactured by Glenmark Pharmaceuticals Ltd. for BluePoint Laboratories. It contains instructions for use, storage conditions, and a warning to keep the drug out of the reach of children. The accompanying medication guide is available online. Contact information for further questions is provided.*
FDA Label Image

Zonisamide Capsules 50mg 100 Capsules Rev 03-17 (Zonisamide Capsules 50mg 100 Capsules Rev 0714)

Zonisamide Capsules 50mg 100 Capsules Rev 03-17 (Zonisamide Capsules 50mg 100 Capsules Rev 0714)
This is a description of a medication containing Zonisamide USP in capsule form, with each capsule containing 50mg of the active ingredient. It is only available with a prescription and comes with a Medication Guide for each patient. The ideal storage temperature is between 15°C and 30°C (59°F to 86°F) in a dry place. This medication is manufactured by Glenmark Pharmaceuticals in India and distributed by BluePoint Laboratories. If you need more information, you can contact them at 1 (888) 7217115.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.